Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1

Journal of Proteome Research

Volumn 6, Issue 10, 2007, Pages 4006-4018

  Rivera Toress, José ^a   Megias, Diego ^b   Bravo Sicilia, Jerónimo ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b Biotechnology Programme   (Spain)

Author keywords

BRMS1; DIGE; Melanoma; Metastasis; Metastasis suppressors; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CATHEPSIN D; CELL EXTRACT; COFILIN 1; HEAT SHOCK PROTEIN 27; LIPOCORTIN 2; POLYPEPTIDE;

ARTICLE; BRMS1 GENE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MASS SPECTROMETRY; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPPRESSOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CARBOCYANINES; CATHEPSIN D; CELL LINE; CELL LINE, TUMOR; DATA INTERPRETATION, STATISTICAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT DYES; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; RNA INTERFERENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 35648989121     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0703167     Document Type: Article

References (54)

1. Zhang, S.; Lin, Q. D.; Di, W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int. J. Gynecol. Cancer 2006, 16 (2), 522-31.
2. Steeg, P. S.; Ouatas, T.; Halverson, D.; Palmieri, D.; Salerno, M. Metastasis suppressor genes: basic biology and potential clinical use. Clin. Breast Cancer 2003, 4 (1), 51-62.
3. Steeg, P. S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12 (8), 895-904.
4. Berger, J. C.; Vander Griend, D. J.; Robinson, V. L.; Hickson, J. A.; Rinker-Schaeffer, C. W. Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol. Ther. 2005, 4 (8), 805-12.
5. Eccles, S. A.; Welch, D. R. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007, 369 (9574), 1742-57.
6. Seraj, M. J.; Samant, R. S.; Verderame, M. F.; Welch, D. R. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 2000, 60 (11), 2764-9.
7. Meehan, W. J.; Welch, D. R. Breast cancer metastasis suppressor 1: update. Clin. Exp. Metastasis 2003, 20 (1), 45-50.
8. Saunders, M. M.; Seraj, M. J.; Li, Z.; Zhou, Z.; Winter, C. R.; Welch, D. R.; Donahue, H. J. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 2001, 61 (5), 1765-7.
9. Liu, Y.; Smith, P. W.; Jones, D. R. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol. Cell. Biol. 2006, 26 (23), 8683-96.
10. Meehan, W. J.; Samant, R. S.; Hopper, J. E.; Carrozza, M. J.; Shevde, L. A.; Workman, J. L.; Eckert, K. A.; Verderame, M. F.; Welch, D. R. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 2004, 279 (2), 1562-9.
11. DeWald, D. B.; Torabinejad, J.; Samant, R. S.; Johnston, D.; Erin, N.; Shope, J. C.; Xie, Y.; Welch, D. R. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res. 2005, 65 (3), 713-7.
12. Cicek, M.; Fukuyama, R.; Welch, D. R.; Sizemore, N.; Casey, G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res. 2005, 65 (9), 3586-95.
13. Van den Bergh, G.; Arckens, L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr. Opin. Biotechnol. 2004, 15 (1), 38-43.
14. Zhou, G.; Li, H.; DeCamp, D.; Chen, S.; Shu, H.; Gong, Y.; Flaig, M.; Gillespie, J. W.; Hu, N.; Taylor, P. R.; Emmert-Buck, M. R.; Liotta, L. A.; Petricoin, E. F., III; Zhao, Y. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 2002, 1 (2), 117-24.
15. Tonge, R.; Shaw, I.; Middleton, B.; Rowlinson, R.; Rayner, S.; Young, J.; Pognan, F.; Hawkins, E.; Currie, I.; Davison, M. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1 (3), 377-96.
16. Blanco-Aparicio, C.; Pequeno, B.; Moneo, V.; Romero, L.; Leal, J. F.; Velasco, J.; Fominaya, J.; Carnero, A. Inhibition of phosphatidylinositol-3- kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria. Anticancer Drugs 2005, 16 (9), 977-87.
17. Yuan, J. S.; Reed, A.; Chen, F.; Stewart, C. N., Jr. Statistical analysis of real-time PCR data. BMC Bioinf. 2006, 7, 85.
18. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25 (4), 402-8.
19. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained Polyacrylamide gels. Anal. Chem. 1996, 68 (5), 850-8.
20. Alfonso, P.; Rivera, J.; Hernaez, B.; Alonso, C.; Escribano, J. M. Identification of cellular proteins modified in response to African swine fever virus infection by proteomics. Proteomics 2004, 4 (7), 2037-46.
21. Peri, S.; Navarro, J. D.; Amanchy, R.; Kristiansen, T. Z.; Jonnalagadda, C. K.; Surendranath, V.; Niranjan, V.; Muthusamy, B.; Gandhi, T. K.; Gronborg, M.; Ibarrola, N.; Deshpande, N.; Shanker, K.; Shivashankar, H. N.; Rashmi, B. P.; Ramya, M. A.; Zhao, Z.; Chandrika, K. N.; Padma, N.; Harsha, H. C.; Yatish, A. J.; Kavitha, M. P.; Menezes, M.; Choudhury, D. R.; Suresh, S.; Ghosh, N.; Saravana, R.; Chandran, S.; Krishna, S.; Joy, M.; Anand, S. K.; Madavan, V.; Joseph, A.; Wong, G. W.; Schiemann, W. P.; Constantinescu, S. N.; Huang, L.; Khosravi-Far, R.; Steen, H.; Tewari, M.; Ghaffari, S.; Blobe, G. C.; Dang, C. V.; Garcia, J. G.; Pevsner, J.; Jensen, O. N.; Roepstorff, P.; Deshpande, K. S.; Chinnaiyan, A. M.; Hamosh, A.; Chakravarti, A.; Pandey, A. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 2003, 13 (10), 2363-71.
22. Strobl, S.; Fernandez-Catalan, C.; Braun, M.; Huber, R.; Masumoto, H.; Nakagawa, K.; Irie, A.; Sorimachi, H.; Bourenkow, G.; Bartunik, H.; Suzuki, K.; Bode, W. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (2), 588-92.
23. Somiari, R. I.; Sullivan, A.; Russell, S.; Somiari, S.; Hu, H.; Jordan, R.; George, A.; Katenhusen, R.; Buchowiecka, A.; Arciero, C.; Brzeski, H.; Hooke, J.; Shriver, C. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3 (10), 1863-73.
24. Garrido, C.; Brunet, M.; Didelot, C.; Zermati, Y.; Schmitt, E.; Kroemer, G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006, 5 (22), 2592-601.
25. Li, D. Q.; Wang, L.; Fei, F.; Hou, Y. F.; Luo, J. M.; Zeng, R.; Wu, J.; Lu, J. S.; Di, G. H.; Ou, Z. L.; Xia, Q. C.; Shen, Z. Z.; Shao, Z. M. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006, 6 (11), 3352-68.
26. Wu, W.; Tang, X.; Hu, W.; Lotan, R.; Hong, W. K.; Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis 2002, 19 (4), 319-26.
27. Bamburg, J. R.; Wiggan, O. P. ADF/cofilin and actin dynamics in disease. Trends Cell Biol. 2002, 12 (12), 598-605.
28. Arber, S.; Barbayannis, F. A.; Hanser, H.; Schneider, C.; Stanyon, C. A.; Bernard, O.; Caroni, P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998, 393 (6687), 805-9.
29. Liaudet-Coopman, E.; Beaujouin, M.; Derocq, D.; Garcia, M.; Glondu-Lassis, M.; Laurent-Matha, V.; Prebois, C.; Rochefort, H.; Vignon, F. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006, 237 (2), 167-79.
30. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113 (6), 685-700.
31. Zhang, Z.; Yamashita, H.; Toyama, T.; Yamamoto, Y.; Kawasoe, T.; Iwase, H. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin. Cancer Res. 2006, 12 (21), 6410-4.
32. Ohta, S.; Lai, E. W.; Pang, A. L.; Brouwers, F. M.; Chan, W. Y.; Eisenhofer, G.; de Krijger, R.; Ksinantova, L.; Breza, J.; Blazicek, P.; Kvetnansky, R.; Wesley, R. A.; Pacak, K. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int. J. Cancer 2005, 114 (1), 139-43.
33. Toshima, J.; Toshima, J. Y.; Amano, T.; Yang, N.; Narumiya, S.; Mizuno, K. Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol. Biol. Cell 2001, 12 (4), 1131-45.
34. Tzivion, G.; Gupta, V. S.; Kaplun, L.; Balan, V. 14-3-3 proteins as potential oncogenes. Semin. Cancer Biol. 2006, 16 (3), 203-13.
35. Toshima, J. Y.; Toshima, J.; Watanabe, T.; Mizuno, K. Binding of 14-3-3beta regulates the kinase activity and subcellular localization of testicular protein kinase 1. J. Biol. Chem. 2001, 276 (46), 43471-81.
36. Hehlgans, S.; Haase, M.; Cordes, N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 2007, 1775 (1), 163-80.
37. Foletta, V. C.; Lim, M. A.; Soosairajah, J.; Kelly, A. P.; Stanley, E. G.; Shannon, M.; He, W.; Das, S.; Massague, J.; Bernard, O. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 2003, 162 (6), 1089-98.
38. Samant, R. S.; Seraj, M. J.; Saunders, M. M.; Sakamaki, T. S.; Shevde, L. A.; Harms, J. F.; Leonard, T. O.; Goldberg, S. F.; Budgeon, L.; Meehan, W. J.; Winter, C. R.; Christensen, N. D.; Verderame, M. F.; Donahue, H. J.; Welch, D. R. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 2000, 18 (8), 683-93.
39. Rothhammer, T.; Poser, I.; Soncin, F.; Bataille, F.; Moser, M.; Bosserhoff, A. K. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 2005, 65 (2), 448-56.
40. Vetvicka, V.; Vetvickova, J.; Benes, P. Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res. 2004, 24 (5A), 2739-43.
41. Cox, G.; O'Byrne, K. J. Matrix metalloproteinases and cancer. Anticancer Res. 2001, 21 (6B), 4207-19.
42. Leto, G.; Tumminello, F. M.; Crescimanno, M.; Flandina, C.; Gebbia, N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin. Exp. Metastasis 2004, 21 (2), 91-106.
43. Gerke, V.; Creutz, C. E.; Moss, S. E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 2005, 6 (6), 449-61.
44. Vishwanatha, J. K.; Chiang, Y.; Kumble, K. D.; Hollingsworth, M. A.; Pour, P. M. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 1993, 14 (12), 2575-9.
45. Yeatman, T. J.; Updyke, T. V.; Kaetzel, M. A.; Dedman, J. R.; Nicolson, G. L. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin. Exp. Metastasis 1993, 11 (1), 37-44.
46. Takamatsu, K.; Noguchi, T. Hippocalcin: a calcium-binding protein of the EF-hand superfamily dominantly expressed in the hippocampus. Neurosci. Res. 1993, 17 (4), 291-5.
47. Maki, M.; Kitaura, Y.; Satoh, H.; Ohkouchi, S.; Shibata, H. Structures, functions and molecular evolution of the penta-EF-hand Ca2+-binding proteins. Biochim. Biophys. Acta 2002, 1600 (1-2), 51-60.
48. Honore, B.; Vorum, H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett. 2000, 466 (1), 11-8.
49. Yabe, D.; Nakamura, T.; Kanazawa, N.; Tashiro, K.; Honjo, T. Calumenin, a Ca2+-binding protein retained in the endoplasmic reticulum with a novel carboxyl-terminal sequence, HDEF. J. Biol. Chem. 1997, 272 (29), 18232-9.
50. Sinha, P.; Kohl, S.; Fischer, J.; Hutter, G.; Kern, M.; Kottgen, E.; Dietel, M.; Lage, H.; Schnolzer, M.; Schadendorf, D. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis 2000, 21 (14), 3048-57.
51. Zhou, Y.; Xu, Y.; Tan, Y.; Qi, J.; Xiao, Y.; Yang, C.; Zhu, Z.; Xiong, D. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk. Res. 2006, 30 (4), 469-76.
52. Kamada, M.; So, A.; Muramaki, M.; Rocchi, P.; Beraldi, E.; Gleave, M. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol. Cancer Ther. 2007, 6 (1), 299-308.
53. Wachsberger, P. R.; Landry, J.; Storck, C.; Davis, K.; O'Hara, M. D.; Owen, C. S.; Leeper, D. B.; Coss, R. A. Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin. Int. J. Hyperthermia 1997, 13 (3), 251-5; discussion 257-9.
54. Vargas-Roig, L. M.; Gago, F. E.; Tello, O.; Aznar, J. C.; Ciocca, D. R. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer 1998, 79 (5), 468-75.